- Report
- October 2024
- 189 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- August 2024
- 100 Pages
Global
From €5904EUR$5,950USD£4,899GBP
- Report
- August 2024
- 138 Pages
Global
From €2976EUR$2,999USD£2,469GBP
- Report
- December 2024
- 173 Pages
Global
From €4912EUR$4,950USD£4,075GBP
- Report
- January 2024
- 200 Pages
Global
From €4962EUR$5,000USD£4,117GBP
- Report
- May 2024
- 200 Pages
Global
From €4118EUR$4,150USD£3,417GBP
- Report
- October 2024
- 193 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- October 2024
- 188 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- April 2024
- 137 Pages
Global
From €2976EUR$2,999USD£2,469GBP
- Report
- January 2024
- 200 Pages
Global
From €4962EUR$5,000USD£4,117GBP
- Report
- April 2024
- 180 Pages
Global
From €4465EUR$4,500USD£3,705GBP
- Report
- January 2024
- 200 Pages
Global
From €4118EUR$4,150USD£3,417GBP
- Report
- February 2023
- 140 Pages
Global
From €4762EUR$4,799USD£3,951GBP
- Report
- March 2022
- 220 Pages
Global
From €4762EUR$4,799USD£3,951GBP
- Report
- April 2023
- 301 Pages
Global
From €4912EUR$4,950USD£4,075GBP
- Report
- March 2023
- 327 Pages
Global
From €3334EUR$3,360USD£2,766GBP
€4168EUR$4,200USD£3,458GBP
- Report
- January 2022
- 115 Pages
Global
From €4713EUR$4,750USD£3,911GBP
- Report
- January 2022
- 115 Pages
Global
From €4713EUR$4,750USD£3,911GBP
- Report
- May 2022
- 192 Pages
Global
From €3160EUR$3,185USD£2,622GBP
€4515EUR$4,550USD£3,746GBP
- Report
- December 2023
- 146 Pages
Global
From €4416EUR$4,450USD£3,664GBP
The Viral Inactivation market is a subset of the biotechnology industry that focuses on the development of technologies and processes to inactivate viruses. This is done through a variety of methods, such as chemical treatments, physical treatments, and irradiation. These treatments are used to reduce the risk of contamination and to ensure the safety of products, such as pharmaceuticals, biologics, and medical devices. Viral inactivation is also used in the production of vaccines and other biologics.
Viral inactivation is an important part of the biotechnology industry, as it helps to ensure the safety of products and reduce the risk of contamination. It is also used to improve the efficacy of products, such as vaccines.
Some companies in the Viral Inactivation market include Merck, Sartorius, Lonza, and Thermo Fisher Scientific. Show Less Read more